Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
Clinical trial NCT01190410 · COMPLETED
Trial details
- NCT number
- NCT01190410
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2017-11-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.